Patrick Kaltenbach Sells 5,000 Shares of Agilent Technologies, Inc. (A) Stock

Agilent Technologies, Inc. (NYSE:A) insider Patrick Kaltenbach sold 5,000 shares of the business’s stock in a transaction on Friday, September 8th. The stock was sold at an average price of $65.26, for a total transaction of $326,300.00. Following the completion of the sale, the insider now owns 45,143 shares in the company, valued at approximately $2,946,032.18. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Patrick Kaltenbach also recently made the following trade(s):

  • On Wednesday, August 23rd, Patrick Kaltenbach sold 5,000 shares of Agilent Technologies stock. The stock was sold at an average price of $63.26, for a total transaction of $316,300.00.
  • On Thursday, July 13th, Patrick Kaltenbach sold 5,000 shares of Agilent Technologies stock. The stock was sold at an average price of $61.26, for a total transaction of $306,300.00.

Shares of Agilent Technologies, Inc. (NYSE A) opened at 66.14 on Wednesday. The stock’s 50 day moving average is $61.78 and its 200 day moving average is $57.69. Agilent Technologies, Inc. has a 12 month low of $42.92 and a 12 month high of $66.42. The stock has a market capitalization of $21.30 billion, a PE ratio of 34.11 and a beta of 1.30.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.07. The firm had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.09 billion. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period last year, the firm posted $0.49 earnings per share. Analysts anticipate that Agilent Technologies, Inc. will post $2.32 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Markets Daily and is the property of of Markets Daily. If you are viewing this report on another publication, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this report can be viewed at https://www.themarketsdaily.com/2017/09/13/patrick-kaltenbach-sells-5000-shares-of-agilent-technologies-inc-a-stock.html.

Several brokerages have commented on A. Jefferies Group LLC boosted their price target on shares of Agilent Technologies from $59.00 to $66.00 and gave the stock a “buy” rating in a research note on Tuesday, May 23rd. Bank of America Corporation reiterated an “equal weight” rating on shares of Agilent Technologies in a research note on Tuesday, August 15th. BidaskClub cut shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Deutsche Bank AG boosted their price target on shares of Agilent Technologies from $58.00 to $62.00 and gave the stock a “buy” rating in a research note on Monday, May 22nd. Finally, Morgan Stanley reiterated an “overweight” rating on shares of Agilent Technologies in a research note on Wednesday, August 16th. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $63.91.

Several large investors have recently bought and sold shares of the company. Advisor Group Inc. lifted its stake in shares of Agilent Technologies by 0.3% in the second quarter. Advisor Group Inc. now owns 3,959 shares of the medical research company’s stock worth $235,000 after buying an additional 10 shares in the last quarter. Bronfman E.L. Rothschild L.P. lifted its stake in shares of Agilent Technologies by 0.8% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 4,658 shares of the medical research company’s stock worth $276,000 after buying an additional 35 shares in the last quarter. Veritable L.P. lifted its stake in shares of Agilent Technologies by 0.4% in the second quarter. Veritable L.P. now owns 10,896 shares of the medical research company’s stock worth $646,000 after buying an additional 40 shares in the last quarter. Park National Corp OH lifted its stake in shares of Agilent Technologies by 1.1% in the second quarter. Park National Corp OH now owns 4,077 shares of the medical research company’s stock worth $242,000 after buying an additional 43 shares in the last quarter. Finally, Trust Co. of Vermont lifted its stake in shares of Agilent Technologies by 1.8% in the second quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock worth $166,000 after buying an additional 50 shares in the last quarter.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Insider Buying and Selling by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply